PMID: 25764684Mar 15, 2015Paper

Interferon-free treatment for patients with chronic hepatitis C

Nihon rinsho. Japanese journal of clinical medicine
Fumitaka Suzuki

Abstract

Oral combinations of direct acting antivirals (interferon-free) improve efficacy and safety outcomes for patients with hepatitis C virus (HCV) infection. In Japanese phase 3 study of daclatasvir plus asunaprevir combination therapy for 24 weeks, 222 patients with chronic HCV genotype 1b infection were enrolled. SVR was achieved by 87% of interferon-ineligible/intolerant patients and 81% of nonresponder patients; rates were similar in cirrhosis (91%) and noncirrhosis (84%) patients, and in patients with IL28B CC (85%) or non-CC (85%) genotypes. The rate of serious adverse events was low among patients. Other oral combination therapies (interferon-free) are ongoing in Japan. Interferon-free all-oral therapy is well tolerated and can achieve a high rate of SVR in patients with HCV genotype 1b.

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.